Hanover is closely monitoring developments surrounding COVID-19 and how it has and may continue to impact the education community. Thisresource center (PDF version here) provides key facts, resources, and potential responses to this rapidly evolving situation, while this visualization dashboard provides an overview of CARES Act funding by agency and award type. In addition, COVID-19 funding opportunities announced in our previous Grant Alerts updates have been gathered here. As always, your dedicated Content Director and Relationship Director also are ready to help with custom research solutions to the challenges you are facing.
* * *
Below is a recap of research funding opportunitiesthat were recently announced, nationwide. Opportunities with a particular focus on COVID-19 are grouped together after non-COVID prospects. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if thereare specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more.
Quick Links to Opportunities
These links will take you directly to the websites of the grant opportunities.
The goals of this Funding Opportunity Announcement are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required. See also this related FOA.
The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased freedom and flexibility to PIs to allow them to redirect their time away from the administrative burden of writing and managing multiple grant applications and towards engaging in the lab. This RPA affords investigators at most career stages the opportunity to advance their long-term research goals, rigorously explore exciting research opportunities, and mentor trainees, which support and align with the mission of NINDS. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by July 1, 2020; full proposals by July 13, 2020.
The Division of Integrative Organismal Systems Core Programs Track supports research aimed at understanding why organisms are structured the way they are and function as they do. Proposals are welcomed in all of the core scientific program areas supported by the IOS. Areas of inquiry include, but are not limited to, developmental biology and the evolution of developmental processes, nervous system development, structure, modification, function, and evolution; biomechanics and functional morphology, physiological processes, symbioses and microbial interactions, interactions of organisms with biotic and abiotic environments, plant and animal genomics, and animal behavior.
The Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences at the National Science Foundation and the National Institute of General Medical Sciences at the National Institutes of Health plan to support fundamental research in mathematics and statistics necessary to answer questions in the biological and biomedical sciences. Both agencies recognize the need to promote research at the interface between mathematical and life sciences. This program is designed to encourage new collaborations, as well as to support innovative activities by existing teams.
The Plant Biotic Interactions (PBI) program supports research on the processes that mediate beneficial and antagonistic interactions between plants and their viral, bacterial, oomycete, fungal, plant, and invertebrate symbionts, pathogens and pests. This joint NSF/NIFA program supports projects focused on current and emerging model and non-model systems, and agriculturally relevant plants. The program’s scope extends from fundamental mechanisms to translational efforts, with the latter seeking to put into agricultural practice insights gained from basic research on the mechanisms that govern plant biotic interactions. Projects must be strongly justified in terms of fundamental biological processes and/or relevance to agriculture and may be purely fundamental or applied or include aspects of both perspectives.
The Centers for Chemical Innovation (CCI) Program supports research centers focused on major, long-term fundamental chemical research challenges. CCIs that address these challenges will produce transformative research, lead to innovation, and attract broad scientific and public interest. CCIs are agile structures that can respond rapidly to emerging opportunities through enhanced collaborations. CCIs integrate research, innovation, education, broadening participation, and informal science communication. Notably, only four grants (of $1.8 million each) will be awarded for Phase I.
This program is intended to facilitate the development of U.S. private industry advanced nuclear reactor demonstrations. It will provide funding for several advanced reactors that are reliable, cost effective, licensable, and commercially viable. These designs are expected to enable a market environment in which commercial reactor services are available that are safe and affordable to both construct and operate when compared to competing, alternative sources of energy in the near- and mid-term. These designs are expected to provide significant improvements in safety, security, economics, and environmental impacts over current nuclear power plant designs. Up to 11 awards will be awarded across all tracks; grants are as high as $80 million.
Eligibility:
Applications are requested from all interested U.S. sources (including IHEs) capable of designing, building, and operating an advanced nuclear reactor demonstration.
This program invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic. AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19.
CHF is currently seeking proposals dedicated to life-changing congenital heart defect research in the areas of clinical cardiology, translational research, population science, and surgical and interventional techniques.
Sponsored by the Neuroendocrine Tumor Research Foundation, the largest private funder of NET research, the North American Neuroendocrine Tumor Society's Basic/Translational Science Investigator Award is designed to encourage scientists at the end of their fellowship who have secured a faculty appointment or scientists beginning their faculty appointment to pursue research focused on neuroendocrine tumors.
Eligibility:
Applicants must be in the first six years of a faculty appointment and a NANETS member.
Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects of SARS-CoV-2 on reproduction, pregnancy, and foetal/neonatal health. The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies; data on the outcome of ongoing fertility care; data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2; and other information related to fertility outcomes.
Eligibility:
Ferring appears to allow U.S.-based reserachers to apply.
The American Diabetes Association is requesting applications for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications. Recent clinical experience has shown that people with diabetes are at higher risk of death from COVID-19 and that COVID-19 drives an increased risk of hyperglycemia and other complications in those with and without diabetes. This is in addition to the risk due to advanced age and chronic disease. Both the biological mechanisms underlying this risk and how to minimize it remain poorly understood. There is an urgent need for research to understand the impact of diabetes on COVID-19 and vice versa.
The Rheumatology Research Foundation is issuing a notice of special interest to highlight the availability of funds for projects exploring the relationships between rheumatic and musculoskeletal diseases and SARS-CoV-2, the virus that causes COVID-19. Grants are up to $400,000 (depending on track).
Eligibility:
Applicants must be ACR/ARP members.
Dates:
LOIs are due by June 1, 2020 for all tracks; applications by July 1 or August 3, 2020, depending on track.
Questions?
We'll be happy to help you find the right grants opportunity for your organization.
CONNECT WITH US
About Hanover Research: Founded in 2003, Hanover Research is a global research and analytics firm that delivers market intelligence through a unique, fixed-fee model to more than 1,000 clients. Headquartered in Arlington, Virginia, Hanover employs high-caliber market researchers, analysts, and account executives to provide a service that is revolutionary in its combination of flexibility and affordability. Hanover was named a Top 50 Market Research Firm by the American Marketing Association in 2015, 2016, and 2017, and has also been twice named a Washington Business JournalFastest Growing Company. To learn more about Hanover Research, visit www.hanoverresearch.com.
Hanover Research LLC 4401 Wilson Blvd Arlington VA 22203
You received this email because you are subscribed to Grant Alerts and Calendars from Hanover Research LLC.
Update your email preferences to choose the types of emails you receive.
